By IDSE News Staff
After Donald Trump was admitted to Walter Reed National Military Medical Center for COVID-19 treatment, he received medications that included the experimental REGN-COV2 antibody cocktail (Regeneron Pharmaceuticals).
REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) designed to block the infectivity of SARS-CoV-2 by binding to the critical receptor-binding domain of the virus’s spike protein. In nonhuman primates, REGN-COV2 reduced the viral